文献
J-GLOBAL ID:202102235187926040
整理番号:21A0021198
結腸直腸癌におけるNOP58動員を介した小核小体RNA仲介2→γ-O-メチル化を促進する長鎖非コードRNA ZFAS1【JST・京大機械翻訳】
Long noncoding RNA ZFAS1 promoting small nucleolar RNA-mediated 2′-O-methylation via NOP58 recruitment in colorectal cancer
著者 (24件):
Wu Huizhe
(Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, People’s Republic of China)
,
Wu Huizhe
(Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation; Liaoning Cancer immune peptide drug Engineering Technology Research Center; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical Univer...)
,
Qin Wenyan
(Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, People’s Republic of China)
,
Qin Wenyan
(Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation; Liaoning Cancer immune peptide drug Engineering Technology Research Center; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical Univer...)
,
Lu Senxu
(Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, People’s Republic of China)
,
Lu Senxu
(Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation; Liaoning Cancer immune peptide drug Engineering Technology Research Center; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical Univer...)
,
Wang Xiufang
(Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, People’s Republic of China)
,
Wang Xiufang
(Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation; Liaoning Cancer immune peptide drug Engineering Technology Research Center; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical Univer...)
,
Zhang Jing
(Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, People’s Republic of China)
,
Zhang Jing
(Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation; Liaoning Cancer immune peptide drug Engineering Technology Research Center; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical Univer...)
,
Sun Tong
(Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, People’s Republic of China)
,
Sun Tong
(Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation; Liaoning Cancer immune peptide drug Engineering Technology Research Center; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical Univer...)
,
Hu Xiaoyun
(Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, People’s Republic of China)
,
Hu Xiaoyun
(Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation; Liaoning Cancer immune peptide drug Engineering Technology Research Center; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical Univer...)
,
Li Yalun
(Department of Anorectal Surgery, First Hospital of China Medical University, Shenyang, People’s Republic of China)
,
Chen Qiuchen
(Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, People’s Republic of China)
,
Chen Qiuchen
(Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation; Liaoning Cancer immune peptide drug Engineering Technology Research Center; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical Univer...)
,
Wang Yuanhe
(Department of Medical Oncology, Cancer Hospital of China Medical University, Shenyang, People’s Republic of China)
,
Zhao Haishan
(Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, People’s Republic of China)
,
Zhao Haishan
(Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation; Liaoning Cancer immune peptide drug Engineering Technology Research Center; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical Univer...)
,
Piao Haiyan
(Department of Medical Oncology, Cancer Hospital of China Medical University, Shenyang, People’s Republic of China)
,
Zhang Rui
(Department of Medical Oncology, Cancer Hospital of China Medical University, Shenyang, People’s Republic of China)
,
Wei Minjie
(Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, People’s Republic of China)
,
Wei Minjie
(Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation; Liaoning Cancer immune peptide drug Engineering Technology Research Center; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical Univer...)
資料名:
Molecular Cancer (Web)
(Molecular Cancer (Web))
巻:
19
号:
1
ページ:
1-22
発行年:
2020年
JST資料番号:
U7336A
ISSN:
1476-4598
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
イギリス (GBR)
言語:
英語 (EN)